Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Magnetic Prefrontal Stimulation for Studying the Role of the Cortex in High-level Cognition Processes and Reward System

This study has been completed.
Sponsor:
Collaborator:
Ben-Gurion University of the Negev
Information provided by (Responsible Party):
Moshe Isserles, Hadassah Medical Organization
ClinicalTrials.gov Identifier:
NCT00912522
First received: June 2, 2009
Last updated: April 20, 2015
Last verified: April 2015

June 2, 2009
April 20, 2015
June 2009
June 2014   (final data collection date for primary outcome measure)
Changes in scoring of different tests and questionnaires [ Time Frame: One year ] [ Designated as safety issue: No ]
Same as current
Complete list of historical versions of study NCT00912522 on ClinicalTrials.gov Archive Site
Correlation of different tests and questionnaires [ Time Frame: One year ] [ Designated as safety issue: No ]
Same as current
Not Provided
Not Provided
 
Magnetic Prefrontal Stimulation for Studying the Role of the Cortex in High-level Cognition Processes and Reward System
Magnetic Prefrontal Stimulation for Studying the Role of the Cortex in High-level Cognition Processes and Reward System
The investigators intend to study the role of the cortex in high- level cognition processes and sensory adaptation, by the use of non-invasive Transcranial Magnetic stimulation and various cognitive tests.
Not Provided
Interventional
Phase 0
Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Double Blind (Subject, Outcomes Assessor)
Primary Purpose: Basic Science
Healthy Volunteers
Device: TMS
TRANSCRANIAL MAGNETIC STIMULATION
  • Active Comparator: LT PFC HIGH FREQ TMS
    Intervention: Device: TMS
  • Active Comparator: LT PFC LOW FREQ TMS
    Intervention: Device: TMS
  • Active Comparator: RT PFC HIGH FREQ TMS
    Intervention: Device: TMS
  • Active Comparator: RT PFC LOW FREQ TMS
    Intervention: Device: TMS
  • Sham Comparator: SHAM STIMULATION
    Intervention: Device: TMS
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
91
June 2014
June 2014   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • healthy men and women, age of 18-60
  • answered negatively to questions of TMS safety questionnaire
  • signed and declared about their agreement to participate in the study
  • hebrew speaker

Exclusion Criteria:

  • self history of significant mental disorder
  • self history or first-degree relatives history of epilepsy
Both
18 Years to 60 Years   (Adult)
Yes
Contact information is only displayed when the study is recruiting subjects
Israel
 
NCT00912522
0116-09-HMO-CTIL
No
Not Provided
Not Provided
Moshe Isserles, Hadassah Medical Organization
Hadassah Medical Organization
Ben-Gurion University of the Negev
Principal Investigator: Moshe Isserles, Dr. Hadassa Medical Organization
Hadassah Medical Organization
April 2015

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP